| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a22000007a 4500 |
| 001 |
in00005771972 |
| 005 |
20260327174719.6 |
| 006 |
m o d |
| 007 |
cr un|---aucuu |
| 008 |
230804s2023 xx o 000 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|c YDX
|d OPELS
|d UKMGB
|d OCLCO
|d UKAHL
|d OCLCF
|d OCLCO
|d N$T
|d UKKRT
|d OCLCL
|d SXB
|d OCLCQ
|d SFB
|
| 015 |
|
|
|a GBC3B1136
|2 bnb
|
| 016 |
7 |
|
|a 021089773
|2 Uk
|
| 019 |
|
|
|a 1400765651
|
| 020 |
|
|
|a 9780323972192
|q (electronic bk.)
|
| 020 |
|
|
|a 0323972195
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323916684
|
| 035 |
|
|
|a (OCoLC)1392044366
|z (OCoLC)1400765651
|
| 037 |
|
|
|a 9780323972192
|b Ingram Content Group
|
| 050 |
|
4 |
|a RS199.5
|
| 082 |
0 |
4 |
|a 615.6
|2 23/eng/20230816
|
| 049 |
|
|
|a TXAM
|
| 245 |
0 |
0 |
|a Advanced and modern approaches for drug delivery /
|c edited by Amit Kumar Kayak [and more].
|
| 260 |
|
|
|a [S.l.] :
|b Academic Press,
|c 2023.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Front Cover -- Advanced and Modern Approaches for Drug Delivery -- Advanced and Modern Approaches for Drug Delivery -- Copyright -- Contents -- Contributors -- 1 -- Novel drug delivery system -- 1. Introduction -- 1.1 Advantages of NDDS -- 2. Novel drug delivery system -- 2.1 Liposomes -- 2.1.1 Composition of liposomes -- 2.1.2 Classification of liposomes -- 2.1.3 Advance and a recent update on the liposomes -- 2.1.3.1 Conventional liposomes comprising a phospholipid -- 2.1.3.2 PEGylated/stealth liposomes -- 2.1.3.3 Ligand-targeted liposomes -- 2.1.3.4 Multifunctional liposomes -- 2.1.4 Liposomes-based marketed products -- 2.2 Transfersomes -- 2.2.1 Merit/demerit of transferesomes -- 2.3 Ethosomes -- 2.3.1 Advantages of ethosomes -- 2.4 Nanoparticles -- 2.4.1 Advantages of nanoparticles -- 2.5 Microspheres -- 2.5.1 Advantages of microspheres -- 2.6 Phytosomes -- 2.6.1 Advantages of phytosomes -- 2.7 Solid lipid nanoparticles -- 2.7.1 Advantage of SLNs -- 2.8 Niosomes -- 2.8.1 Advantages of niosomes -- 2.9 Proniosomes -- 2.9.1 Advantages of proniosomes -- 2.10 Liquid crystals -- 2.10.1 Advantages of liquid crystals -- 2.11 Dendrimer -- 2.11.1 Advantages of dendrimers -- 2.12 Hydrogels -- 2.12.1 Advantages of hydrogels -- 3. Conclusion -- References -- Further reading -- 2 -- Self-emulsifying systems for drug delivery: advances and challenges -- 1. Introduction -- 2. Construction of pseudoternary phase diagrams -- 3. Self-emulsifying systems for oral drug delivery -- 3.1 General components of SEDDSs for oral drug delivery -- 3.2 Applications of SEDDSs for oral drug delivery -- 3.2.1 Liquid SEDDSs for oral drug delivery -- 3.2.2 Solid SEDDSs (S-SEDDSs) for oral drug delivery -- 3.2.3 Supersaturable SEDDSs for oral drug delivery -- 4. Self-emulsifying ocular drug delivery systems -- 5. Self-emulsifying dermal and transdermal drug delivery systems.
|
| 505 |
8 |
|
|a 5.1 Transdermal drug delivery -- 5.2 Targeted delivery to skin strata -- 6. Self-emulsifying vaginal drug delivery systems -- 7. Self-emulsifying rectal drug delivery systems -- 8. Self-emulsifying parenteral drug delivery systems -- 9. Concluding remarks -- References -- 3 -- Gastroretentive drug delivery approaches: concepts, approaches, and applications -- 1. Introduction -- 2. Gastroretentive drug delivery systems -- 3. Anatomy and physiology of the stomach -- 4. Factors affecting gastric retention ability of a delivery system -- 5. Approaches to developing GRDDS -- 5.1 Mucoadhesive systems -- 5.2 High-density systems -- 5.3 Floating systems -- 6. Swellable and expandable systems -- 7. Magnetic systems -- 8. Application of gastroretentive dosage forms -- 9. Conclusion -- References -- 4 -- Current advancements in nasopulmonary drug delivery systems -- 1. Introduction -- 2. Anatomy and physiology of the respiratory system -- 3. Advantages and limitations of the nasopulmonary route -- 3.1 Mucociliary clearance -- 3.2 Alveolar macrophages -- 3.3 Enzymatic degradation -- 3.4 Rapid systemic absorption -- 4. Factors determining pulmonary drug distribution, effectiveness, and clearance -- 4.1 Particle size -- 4.2 Particle shape -- 4.3 Stealth ability -- 5. Materials selection for NPDDSSs -- 6. Applications of NPDDSs -- 7. Methods of targeting in NPDDSs -- 8. Next-generation impactor devices as lung simulators -- Acknowledgement -- References -- 5 -- Osmotic drug deliverance systems: concepts, approaches, and applications -- 1. Introduction -- 2. Controlled drug deliverance by osmosis machineries -- 3. Concept of osmosis -- 4. Basic ingredients of osmotic machineries -- 4.1 Medication -- 4.2 Osmotic agent -- 4.3 Semipenetrable membrane -- 4.4 Substance for semipenetrable membrane -- 4.4.1 Cellulose acetate membrane -- 4.4.2 Compound polyamide membrane.
|
| 505 |
8 |
|
|a 4.4.3 Arbitrary feature of semipenetrable membrane -- 4.5 Hole forming factors -- 4.6 Covering solvent -- 4.7 Emulsifying agents -- 4.8 Flux moderating factors -- 4.9 Wicking factors -- 4.10 Barrier cortex formers -- 4.11 Plasticizers -- 5. Sorts of osmotically controlled drug deliverance devices -- 5.1 Oral osmotic drug deliverance devices -- 5.1.1 Single chamber osmotic pump -- 5.1.1.1 Elementary osmotic pump (EOP) -- 5.1.1.2 Controlled porosity of osmotic pump (COP) -- 5.1.1.3 Osmotic erupting osmotic pump -- 5.1.2 Multichamber osmotic pump -- 5.1.2.1 Push-pull osmotic pump -- 5.1.2.2 Osmotic pump with nonextending secondary section -- 5.1.2.3 Sandwich osmotic tablets (SOTS) -- 5.2 Implantable osmotic drug deliverance devices -- 5.2.1 Rose and nelson pump -- 5.2.2 Higuchi leeper pump -- 5.2.3 Higuchi theeuwes pump -- 5.2.4 Oral osmotic capsules -- 5.2.4.1 OROS-CT -- 5.2.4.2 Liquid oral release osmotic system (L-OROS) -- 5.2.4.3 Multiparticulate delayed release systems -- 5.2.4.4 Telescopic capsule for postponed diffusion -- 6. Conclusion -- References -- 6 -- Nanogels as drug delivery platform -- 1. Introduction -- 2. Bibliometric analysis of the nanogels as drug delivery platform -- 3. Drug release -- 4. Nanogels as a drug delivery platform in different systems -- 5. Other applications -- 6. Global market report -- 7. Disadvantages of the use of nanogels as drug carriers -- 8. Conclusions -- References -- 7 -- Nanoliposomes as safe and efficient drug delivery nanovesicles -- 1. Introduction -- 2. Nanoliposomes preparation -- 2.1 Chemical components -- 2.2 Methods of preparation -- 2.2.1 Thin-layer hydration -- 2.2.2 Reverse-phase evaporation -- 2.2.3 Solvent injection -- 2.2.4 Heating method -- 2.2.5 Freeze-drying method -- 2.2.6 Microfluidics channel -- 2.2.7 Supercritical fluids -- 3. Methods of drug loading -- 3.1 Passive loading techniques.
|
| 505 |
8 |
|
|a 3.2 Active loading techniques -- 3.2.1 pH gradient -- 3.2.2 Ammonium sulfate gradient -- 3.2.3 Metal-ion complexation gradient -- 4. Analysis and characterization of nanoliposomes -- 4.1 Particle size and morphology -- 4.2 Surface charge -- 4.3 Zeta potential -- 4.4 Polydispersity index -- 4.5 Encapsulation efficiency and loading capacity -- 4.6 Drug release -- 5. Types of nanoliposomes in drug delivery -- 5.1 Conventional nanoliposomes -- 5.2 PEGylated nanoliposomes -- 5.3 Coated nanoliposomes -- 5.4 Targeted nanoliposomes -- 5.5 Stimulus-responsive nanoliposomes -- 6. Stability and safety of nanoliposomes -- 7. Applications of nanoliposomes in treatment of human diseases -- 7.1 Treatment of cancer -- 7.1.1 Passive delivery -- 7.1.2 Targeted delivery -- 7.1.3 Stimulus responsive delivery -- 7.2 Treatment of neurological disorders -- 7.3 Treatment of liver diseases -- 8. Nanoliposomal vaccines -- 9. Nanoliposomal bioreactors -- 10. Nanoliposomes in theranostics -- 11. Marketed nanoliposomes and future challenges -- 12. Conclusions -- References -- 8 -- Transferosomes: a novel nanotechnological approach for transdermal drug delivery -- 1. Introduction -- 2. Transferosomes -- 3. Advantages of transferosomes -- 4. Limitations of transferosomes -- 5. Composition of transferosomes -- 6. Mechanism of penetration of transferosomes across stratum corneum -- 7. Methods of transferosome preparation -- 7.1 Vortexing-sonication -- 7.2 Rotary film evaporation -- 7.3 Reverse-phase evaporation -- 7.4 Freeze-thaw method -- 7.5 Ethanol injection -- 7.6 Homogenization/extrusion -- 7.7 Protransferosome-transferosome method -- 7.8 Microfluidics method -- 8. Characterizations of transferosomes -- 8.1 Vesicle size and distribution -- 8.2 Zeta-potential -- 8.3 Drug entrapment efficiency -- 8.4 Surface topography -- 8.5 Number of vesicles per cubic mm -- 8.6 Drug content.
|
| 505 |
8 |
|
|a 8.7 Turbidity measurement -- 8.8 Measurement of degree of deformability or permeability -- 8.9 Penetration ability -- 8.10 Occlusion effects -- 8.11 Confocal scanning laser microscopy (CSLM) study -- 8.12 In vitro drug release evaluation -- 8.13 In vitro skin permeation study -- 9. Applications of transferosomes -- 9.1 Protein and peptide delivery -- 9.2 Corticosteroids -- 9.3 Anticancer drugs -- 9.4 Anaesthetics -- 9.5 Nonsteroidal anti-inflammatory drugs (NSAIDs) -- 9.6 Antipsycotic drugs -- 10. Conclusions -- References -- 9 -- Niosomes as a promising nanovesicular drug delivery -- 1. Introduction -- 2. Composition of niosomes -- 2.1 Nonionic surfactants -- 2.2 Cholesterol -- 2.3 Charge inducer molecules -- 2.4 Hydration medium -- 3. Factors affecting niosomal formulation -- 3.1 Surfactant -- 3.2 Cholesterol -- 3.3 Drug -- 3.4 Hydration condition -- 3.5 Resistance to osmotic stress -- 3.6 Method of preparation -- 4. Types of niosomes -- 5. Fabrication methods of niosomes -- 5.1 Thin layer evaporation/handshaking -- 5.2 Reverse phase evaporation -- 5.3 Bubble -- 5.4 Ether injection -- 5.5 Sonication -- 5.6 Microfluidization -- 5.7 Transmembrane pH gradient -- 5.8 Membrane extrusion -- 5.9 Single pass -- 5.10 Handjani-vila -- 5.11 Heating -- 5.12 Freeze and thaw -- 5.13 Enzymatic -- 5.14 Microfluidic hydrodynamic focusing -- 5.15 Dehydration-rehydration -- 5.16 Supercritical carbon dioxide fluid (scCO2) -- 5.17 Lipid injection -- 5.18 Emulsion -- 5.19 Formation of niosomes from proniosomes -- 6. Methods for controlling the size of niosomes -- 6.1 Fractionation -- 6.2 Homogenization -- 6.3 Extrusion -- 7. Niosome purification -- 7.1 Dialysis -- 7.2 Reverse dialysis -- 7.3 Gel filtration/column chromatography -- 7.4 Centrifugation -- 7.5 Ultra-centrifugation -- 8. Characterization of niosomes -- 8.1 Size, morphology, and size distribution.
|
| 520 |
|
|
|a "Advanced and Modern Approaches for Drug Delivery explores novel approaches currently used for drug delivery, including the must up-to-date techniques and technology. The approaches discussed allow pharmaceutical scientists to design effective drug delivery systems or devices for the management and treatment of numerous diseases and conditions. Detailed information on a wide variety of subjects, including dendrimers, lipid nanostructures, solid lipid nanoparticles, stimuli-responsive smart systems, self-assembled protein-drug nanoparticles, nanoconjugate formulations, nanofibers, iontophoretic systems, microneedle systems, ultra-sound triggered systems, targeted carrier-based intracellular delivery systems, resealed erythrocyte-based systems, 3 D-printing tool, site-specific monoclonal antibodies, and bio-inspired systems are all comprehensively discussed." --Provided by publisher.
|
| 650 |
|
0 |
|a Drug delivery systems.
|
| 650 |
|
2 |
|a Drug Delivery Systems
|
| 650 |
|
6 |
|a Systèmes d'administration de médicaments.
|
| 650 |
|
7 |
|a Drug delivery systems
|2 fast
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 700 |
1 |
|
|a Kayak, Amit Kumar.
|
| 710 |
2 |
|
|a ScienceDirect (Online service)
|
| 776 |
0 |
8 |
|i Print version:
|z 9780323972192
|
| 776 |
0 |
8 |
|i Print version:
|z 0323916686
|z 9780323916684
|w (OCoLC)1329423715
|
| 776 |
0 |
8 |
|i Print version:
|t ADVANCED AND MODERN APPROACHES FOR DRUG DELIVERY.
|d [S.l.] : ELSEVIER ACADEMIC PRESS, 2023
|z 0323916686
|w (OCoLC)1329423715
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://www.sciencedirect.com/science/book/9780323916684
|z Connect to the full text of this electronic book
|t 0
|
| 955 |
|
|
|a Elsevier ScienceDirect 2026-2027
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
f |
f |
|i 1148d794-145f-4ffa-9f2d-fca0e85817b3
|s 151c15ee-7aa1-4ae5-9ece-cf71b21b0016
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|s www_evans
|d Available Online
|t 0
|e RS199.5
|h Library of Congress classification
|
| 998 |
f |
f |
|a RS199.5
|t 0
|l Available Online
|